Latest News

See All Latest News Right Pointing Arrow
Breast cancer ribbon image
HOPA News Late Breaking News

Late-Breaking HOPA News: Ribociclib in the Adjuvant Setting for Early-Stage High Risk HR-Positive, HER2-Negative Breast Cancer

December 23, 2024

Clarissa Wilkins, PharmD, BCOP, and Anne DeLisa, PharmD, CCRP, dive deeper into ribociclib (Kisqali) after its FDA approval in September 2024.

IV bag
HOPA News Late Breaking News

Late-Breaking HOPA News: Navigating the Nationwide IV Fluid Shortage and Its Toll on Oncology Care

December 19, 2024

Ashley Jones, PharmD, BCOP; Sanja Zepcan, PharmD; and Emily Rux, PharmD, BCOP, discuss the impact of current nationwide IV fluid shortages.

Breast cancer image
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Sacituzumab govitecan-hziy

December 12, 2024

Brooke Kielkowski, PharmD, PGY2 Oncology Pharmacy Resident, and Jordan Hill, PharmD, BCOP, Pharmacy Clinical Specialist, both from WVU Medicine - West Virginia University Hospitals, Morgantown, WV, write about sacituzumab govitecan-hziy (Trodelvy).

stomach cancer image
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Zolbetuximab-clzb

December 12, 2024

Olivia Tholt, PharmD, PGY2 Oncology Pharmacy Resident, and Sarah Cimino, PharmD, BCOP, Clinical Pharmacist Specialist, Gastrointestinal Oncology, both from Vanderbilt University Medical Center, Nashville, TN, write about zolbetuximab-clzb (Vyloy).

Oncology Stewardship
Late Breaking News

Oncology Stewardship Practice in the United States: A Hematology/Oncology Pharmacy Association National Survey

November 26, 2024

A recently published survey looks to gain insight on the current landscape of oncology stewardship in the United States.

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Vorasidenib

November 20, 2024

Lacy La Fever, PharmD, MS, PGY2 Oncology Pharmacy Resident, and Anastasia Graham, PharmD, MBA, BCOP, Clinical Oncology Specialist, Neuro-oncology, both from Medical University of South Carolina, Charleston, SC, write about vorasidenib (Voranigo).

Explore more from HOPA

-positive non-small cell lung cancer
Drug Updates

Pharmacist’s Application to Practice: Repotrectinib

January 25, 2024

Christopher L. Cornett II, PharmD PGY1 Acute Care Pharmacy Resident Anne E Hitron, PharmD, MS, MBA, BCOP ,Oncology Pharmacy Specialist, Baptist Health Louisville, Louisville, Kentucky

Metastatic Colorectal Cancer
Journal Club

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

May 04, 2024

The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously

Late Breaking News

Clinical Oncology Pharmacy Technician: Impact of a New Role on Pharmacy and Patient Metrics at a Large Academic Cancer Center

September 20, 2024

A recently published article details the impact of having an inpatient clinical oncology pharmacy technician program.

uveal melanoma with unresectable hepatic metastases
Drug Updates

Pharmacist’s Application to Practice: Hepzato Kit™

January 11, 2024

Lainey Vargo, PharmD, PGY2-Oncology Resident Katie Murto, PharmD, BCOP and Crystal Heise, PharmD, BCOP WVUH Hospitals, Morgantown, West Virginia.

Journal Club

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

October 23, 2023

Amivantamab–chemotherapy improved PFS and intracranial PFS versus chemotherapy.

Oncology Stewardship
Late Breaking News

Oncology Stewardship Practice in the United States: A Hematology/Oncology Pharmacy Association National Survey

November 26, 2024

A recently published survey looks to gain insight on the current landscape of oncology stewardship in the United States.

Myelofibrosis with anemia
Drug Updates

Pharmacist's Application to Practice: Momelotinib

January 11, 2024

Diana Mansour, PharmD, BCOP, Clinical Pharmacy Specialist, Charles M Gallagher, PharmD, PGY2 Oncology Pharmacy Resident; Kelsea Seago, PharmD, BCOP, Clinical Pharmacy Specialist, allfrom WVUH Hospitals, write about Momelotinib.

metastatic non-small cell lung cancer
Journal Club

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

November 23, 2023

First-line treatment with osimertinib–chemotherapy led to significantly longer progression-free survival than osimertinib monotherapy among patients with EGFR-mutated advanced NSCLC.

Visual of data being collected
Late Breaking News

Oncology Pharmacy Staffing Survey Across Practice Settings in the United States

September 19, 2024

The results of a recently published pharmacy staffing model survey has brought new insights into oncology pharmacy operations across the country.